相关实验视频

Updated: Jul 10, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

血栓吸收对ST段升高心肌梗塞患者左心室重塑和功能的影响:随机对照试验的元分析

Emiliano Bianchini¹, Marco Lombardi¹, Angela Buonpane¹

¹Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica Sacro Cuore, Rome, Italy.

International journal of cardiology

|November 18, 2023

概括

在ST段升高心肌梗塞 (STEMI) 中,血栓吸收 (TA) 改善左心室 (LV) 功能,特别是在手动技术和左前下降动脉参与的情况下. 这次RCT的元分析突出了TA的特点.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
临床试验临床试验

背景情况:

在ST段升高心肌梗塞 (STEMI) 中的例行血栓吸收 (TA) 没有显示出一致的临床结果改善.
之前的元分析表明,TA对高血栓负担患者的潜在益处.
在STEMI后,TA对左心室 (LV) 功能恢复和重塑的影响仍在争论中.

研究的目的:

在STEMI患者中评估血栓吸收 (TA) 对左心室 (LV) 功能恢复和重塑在初级穿皮冠状动脉干预 (pPCI) 后的影响.
从随机对照试验 (RCT) 汇集数据,以澄清TA在STEMI后 LV重塑中的作用.
为了在STEMI患者中比较手动TA与机械TA.

主要方法:

在PubMed和CENTRAL数据库中系统地搜索相关的随机对照试验 (RCT) 的文献.
主要结局指标包括 LV 喷射分数 (LVEF),LV 终端扩张体积 (LVEDV),LV 终端缩体积 (LVESV) 和墙壁运动得分指数 (WMSI).
预先规定的子组分析比较了手动血栓吸收 (TA) 与机械TA.

主要成果:

总共分析了28项涉及4990名患者的研究.
与对照组相比,血栓吸收 (TA) 与较低的墙壁运动得分指数 (WMSI) 有关.
与对照组相比,手动TA显示了较大的LV射出分数 (LVEF) 和较小的LV末缩体积 (LVESV). 超回归表明TA的使用,特别是在左前下垂动脉 (LAD) 的参与,减少LVEDV和LVESV,改善心肌救援指数.

结论:

血栓吸收 (TA) 与心肌梗塞后左心室 (LV) 功能增强有关.
在改善心脏病发作后的LV重塑中,TA的有效性似乎受到TA技术,缺血的持续时间和左前下降动脉 (LAD) 的参与的影响.

关键词:

左心室的功能是没有的.左心室重塑的左心室重塑主要的穿皮冠状动脉干预.ST段升高心肌梗塞的心脏病发作血栓的吸收是因为吸收.

更多相关视频

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...